Skip to main content
Bradley Pua, MD, Interventional Radiology, New York, NY

Bradley B Pua MD


Division Chief, Interventional Radiology, Weill Cornell Medicine Director, Lung Screening Program

Request appointment
  • 525 E 68th StreetNew York, NY 10065

  • Book by Phone+1(657) 566-4705

  • Fax+1 646-962-0941

Overview of  Dr. Pua

Dr. Bradley Pua is a radiologist in New York, NY and is affiliated with NewYork-Presbyterian/Weill Cornell. He received his medical degree from NYU School of Medicine and has been in practice 14 years. He specializes in vascular & interventional radiology.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Radiology-Diagnostic, 2007 - 2011
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 2006 - 2007
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Surgery, 2003 - 2006
  • New York University School of Medicine
    New York University School of MedicineClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2027
  • Interventional Radiology and Diagnostic Radiology
    American Board of Radiology Interventional Radiology and Diagnostic Radiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Updates and Challenges in Lung Cancer 
    Columbia University, Department of Surgery, New York, New York - 6/21/2013

Press Mentions

  • New Mobile Lung Cancer Screening Unit Launches to Improve Access to Care for New Yorkers
    New Mobile Lung Cancer Screening Unit Launches to Improve Access to Care for New YorkersOctober 15th, 2025
  • Federal Task Force Expands Screening Recommendations to Include Current and Former Smokers Ages 50-80
    Federal Task Force Expands Screening Recommendations to Include Current and Former Smokers Ages 50-80March 9th, 2021
  • PharmaCyte Biotech Completes Medical Manual for IND Filing
    PharmaCyte Biotech Completes Medical Manual for IND FilingMay 4th, 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: